News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
He Junli
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/10/2023 |
4/A
| He Junli (CEO) has filed a Form 4 on Biostage, Inc.|
Txns:
| Granted 267,616 options to buy
@ $6.08, valued at
$1.6M
|
|
| 01/05/2023 |
4
| He Junli (Director) has filed a Form 4 on Biostage, Inc.|
Txns:
| Sold 135 shares
@ $6.83, valued at
$922.1 |
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2021 |
4
| He Junli (Director) has filed a Form 4 on Biostage, Inc.|
Txns:
| Granted 10,895 options to buy
@ $2.75, valued at
$30k
Granted 8,727 options to buy
@ $2.75, valued at
$24k
|
|
| 11/10/2021 |
3
| He Junli (Director) has filed a Form 3 on Biostage, Inc. |
|
|